Related Experiment Video
Updated: Mar 12, 2026

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
Categorization of Patients with Peripheral Artery Disease by Charlson Comorbidity Index
Max Meertens1, Volker H Schmitt1,2, Igli Kalaja1
1University Medical Centre of the Johannes Gutenberg University, Department of Cardiology, Mainz, Germany.
Insights
Peripheral artery disease (PAD) patients show increasing comorbidity burden. Higher burden, measured by the Charlson Comorbidity Index (CCI), significantly elevates risks for major adverse events and mortality.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Geriatrics
Background:
- Peripheral artery disease (PAD) is a significant cause of atherosclerotic morbidity.
- The impact of comorbidity burden on PAD patient prognosis is often underestimated.
- The Charlson Comorbidity Index (CCI) is a standard measure for assessing comorbidity burden.
Purpose of the Study:
- To analyze trends in comorbidity burden among PAD patients in Germany.
- To evaluate the association between comorbidity burden and clinical outcomes in PAD.
- To inform clinical practice regarding comorbidity management in PAD.
Main Methods:
- Utilized German nationwide inpatient data from 2005-2022 for PAD hospitalizations.
- Categorized patients into CCI classes: mild (1-2), moderate (3-4), and high severity (>4).
- Analyzed trends in CCI class distribution and its correlation with treatment and outcomes.
Main Results:
- Over 3 million PAD hospitalizations were analyzed, with 55.4% in the high-severity CCI class by 2022.
- Comorbidity burden and high-severity CCI class prevalence increased from 2006 to 2022.
- Higher CCI class correlated with increased endovascular treatment, and significantly elevated risks for MACCE (OR 9.66), amputation (OR 2.82), and in-hospital mortality (OR 9.87).
Conclusions:
- PAD patient comorbidity burden has risen in Germany between 2005-2022.
- Elevated CCI scores in PAD patients are linked to a nearly 10-fold increased risk of MACCE and mortality.
- Optimizing comorbidity management is crucial for improving PAD patient outcomes and preventing complications.
Background:
Peripheral artery disease (PAD) is the third leading cause of atherosclerotic morbidity. The influence of comorbidity burden on the prognosis of PAD patients is still underestimated. The Charlson Comorbidity Index (CCI) is an established tool for evaluating patients' comorbidity burden.
Methods:
We used the German nationwide inpatient statistics including all hospitalizations of patients admitted due to PAD in Germany 2005-2022 and categorized according CCI classes (mild: CCI=1-2points, moderate: CCI=3-4points, high severity: CCI>4points).
Results:
Overall, 3,167,987 hospitalizations of PAD patients were included in our study. Of these, 10.3% were categorized as mild, 34.3% as moderate and 55.4% as high-severity CCI class. Comorbidity burden and particularly frequency of high-severity CCI class increased from 51.2% (2006) to 58.5% (2022).An increase in the CCI class was associated with increased likelihood of being treated endovascularly (OR 1.48, 95%CI 1.48-1.49, P<0.001) rather than surgically (OR 0.87, 95%CI 0.87-0.88, P<0.001). An increase in the CCI class was associated with an elevated risk for major adverse cardiovascular and cerebrovascular events (MACCE) (OR 9.66, 95%CI 9.45-9.88, P<0.001), amputation (OR 2.82, 95%CI 2.80-2.84, P<0.001) and in-hospital case-fatality (OR 9.87, 95%CI 9.62-10.12, P<0.001).
Conclusion:
PAD patients' comorbidity burden increased during the observational period between 2005 and 2022 in Germany. Higher comorbidity burden mirrored by higher CCI class was associated with an approximately 10-fold increased risk for MACCE and in-hospital mortality. Physicians have to be aware for the impact of comorbidity burden and optimization of the comorbidities is an important focus to improve outcomes and prevent complications.
More Related Videos
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Angina II: Classification